BioVie Inc. (BIVI) stock
BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
$0.94−0.05 (-5.27%)
Close on Nov 18, 2026Market cap $7.11MP/E –Yield –
BioVie price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
No price to sales ratio figures for BioVie
BioVie has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?